NONCONSOLIDATED AFFILIATES	9 Months Ended
Sep. 30, 2026
Equity Method Investments and Joint Ventures [Abstract]
NONCONSOLIDATED AFFILIATES	NONCONSOLIDATED AFFILIATES The Company's investments in affiliates accounted for using the equity method ("nonconsolidated affiliates") are recorded in "Investments and noncurrent receivables" in the interim Condensed Consolidated Balance Sheets. The Company's net investment in nonconsolidated affiliates at September 30, 2026 and December 31, 2025 was $462 million and $111 million, respectively. Sales to nonconsolidated affiliates represented less than 1 percent of total net sales for the three and nine months ended September 30, 2026 and 2025. There were no purchases from nonconsolidated affiliates for the three and nine months ended September 30, 2026 and 2025. The Company maintained an ownership interest in three nonconsolidated affiliates at September 30, 2026, including approximately a 16 percent non-controlling equity interest in Arclin and a 19.9 percent non-controlling equity interest in Derby Group Holdings LLC ("Derby"). The Company recorded nonconsolidated affiliate income of $5 million and zero for the three months ended September 30, 2026 and 2025, respectively, and income of $13 million and a loss of $6 million for the nine months ended September 30, 2026 and 2025, respectively, reported in "Equity in earnings (loss) of nonconsolidated affiliates" in the interim Consolidated Statements of Operations. Financial results of the Arclin and Derby equity interests are included in DuPont's interim Consolidated Financial Statements with a three-month lag, using the equity method of accounting and with intercompany profits eliminated in accordance with DuPont’s accounting policy. The amounts related to the Arclin and Derby equity interests are recorded within Corporate. The carrying value of the Arclin equity interest was $324 million as of September 30, 2026. The carrying values of the Derby equity interest as of September 30, 2026 and December 31, 2025 were $137 million and $111 million, respectively. Aramids Note Receivable For the three and nine months ended September 30, 2026, the Company recognized non-cash interest income related to the Aramids Note Receivable of $6 million and $11 million, respectively. This income was reported in "Sundry income (expense) - net" on the interim Consolidated Statements of Operations, and accreted to the carrying value of the note receivable. The carrying value of the note receivable as of September 30, 2026 was $194 million, recorded in "Investments and noncurrent receivables" in the interim Condensed Consolidated Balance Sheets. Derby Note Receivable As a result of the Delrin® Divestiture, on November 1, 2023, DuPont received a note receivable of $350 million (the "Derby Note Receivable"). The Company recognized non-cash interest income related to the Derby Note Receivable of $8 million and $7 million for the three months ended September 30, 2026 and 2025, respectively, and $23 million and $20 million for the nine months ended September 30, 2026 and 2025, respectively. This income was reported in "Sundry income (expense) - net" on the interim Consolidated Statements of Operations, and accreted to the carrying value of the note receivable. The carrying values of the note receivable as of September 30, 2026 and December 31, 2025 were $305 million and $265 million, respectively, recorded in "Investments and noncurrent receivables" in the interim Condensed Consolidated Balance Sheets.

NONCONSOLIDATED AFFILIATES

9 Months Ended

Sep. 30, 2026

Equity Method Investments and Joint Ventures [Abstract]

The Company's investments in affiliates accounted for using the equity method ("nonconsolidated affiliates") are recorded in "Investments and noncurrent receivables" in the interim Condensed Consolidated Balance Sheets. The Company's net investment in nonconsolidated affiliates at September 30, 2026 and December 31, 2025 was $462 million and $111 million, respectively.

Sales to nonconsolidated affiliates represented less than 1 percent of total net sales for the three and nine months ended September 30, 2026 and 2025. There were no purchases from nonconsolidated affiliates for the three and nine months ended September 30, 2026 and 2025.

The Company maintained an ownership interest in three nonconsolidated affiliates at September 30, 2026, including approximately a 16 percent non-controlling equity interest in Arclin and a 19.9 percent non-controlling equity interest in Derby Group Holdings LLC ("Derby"). The Company recorded nonconsolidated affiliate income of $5 million and zero for the three months ended September 30, 2026 and 2025, respectively, and income of $13 million and a loss of $6 million for the nine months ended September 30, 2026 and 2025, respectively, reported in "Equity in earnings (loss) of nonconsolidated affiliates" in the interim Consolidated Statements of Operations. Financial results of the Arclin and Derby equity interests are included in DuPont's interim Consolidated Financial Statements with a three-month lag, using the equity method of accounting and with intercompany profits eliminated in accordance with DuPont’s accounting policy. The amounts related to the Arclin and Derby equity interests are recorded within Corporate.

The carrying value of the Arclin equity interest was $324 million as of September 30, 2026. The carrying values of the Derby equity interest as of September 30, 2026 and December 31, 2025 were $137 million and $111 million, respectively.

Aramids Note Receivable

For the three and nine months ended September 30, 2026, the Company recognized non-cash interest income related to the Aramids Note Receivable of $6 million and $11 million, respectively. This income was reported in "Sundry income (expense) - net" on the interim Consolidated Statements of Operations, and accreted to the carrying value of the note receivable. The carrying value of the note receivable as of September 30, 2026 was $194 million, recorded in "Investments and noncurrent receivables" in the interim Condensed Consolidated Balance Sheets.

Derby Note Receivable

As a result of the Delrin® Divestiture, on November 1, 2023, DuPont received a note receivable of $350 million (the "Derby Note Receivable"). The Company recognized non-cash interest income related to the Derby Note Receivable of $8 million and $7 million for the three months ended September 30, 2026 and 2025, respectively, and $23 million and $20 million for the nine months ended September 30, 2026 and 2025, respectively. This income was reported in "Sundry income (expense) - net" on the interim Consolidated Statements of Operations, and accreted to the carrying value of the note receivable. The carrying values of the note receivable as of September 30, 2026 and December 31, 2025 were $305 million and $265 million, respectively, recorded in "Investments and noncurrent receivables" in the interim Condensed Consolidated Balance Sheets.